NOD2 and digestive system disorder: However, an epidemiology research including 40,000 participants indicated that NOD2 polymorphism may not be the predominant risk factor for gastrointestinal disorders, although the NOD2 relationship with gastrointestinal cancer cannot be fully ruled out [51].